Vir Biotechnology Inc (VIR)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	-521,960	-615,061	515,837	528,584	-298,665
Revenue	US$ in thousands	74,205	86,180	1,580,470	1,087,070	76,368
Net profit margin		-703.40%	-713.69%	32.64%	48.62%	-391.09%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $-521,960K ÷ $74,205K
= -703.40%

The net profit margin of Vir Biotechnology Inc has displayed significant fluctuation over the years, as per the data provided.

In December 31, 2020, the company reported a negative net profit margin of -391.09%, indicating that the company incurred heavy losses relative to its revenue during that year.

Subsequently, there was a substantial improvement in December 31, 2021, with the net profit margin increasing to 48.62%, signifying that the company generated a significant profit relative to its revenue.

The trend continued positively into December 31, 2022, where the net profit margin stood at 32.64%, demonstrating that the company maintained profitability, albeit at a slightly lower margin compared to the previous year.

However, in December 31, 2023, the net profit margin recorded a sharp decline, falling to -713.69%, indicating an extremely high loss compared to revenue, which is a concerning trend.

This negative trend persisted into December 31, 2024, as the net profit margin further declined to -703.40%, reflecting continued challenges in generating profitability and significant losses relative to revenue.

In conclusion, the analysis of the net profit margin of Vir Biotechnology Inc reveals a volatile performance, with periods of profitability followed by substantial losses. Further investigation into the company's financial health, operational efficiency, and strategic direction may be imperative to address the erratic nature of its net profit margin.